The Evidence Clash Between Statins and Delirium: Should They Stay, Should They Go, or Should They Be Started?

Crit Care Med. 2017 Sep;45(9):1574-1576. doi: 10.1097/CCM.0000000000002559.

Authors

Matthew S Duprey¹, Sara A Zekery-Saad, John W Devlin

Affiliation

¹ School of Pharmacy, Northeastern University; and Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, MA School of Pharmacy, Northeastern University, Boston, MA School of Pharmacy, Northeastern University; and Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, MA.

PMID: 28816845
DOI: 10.1097/CCM.0000000000002559

No abstract available

Publication types

Editorial
Comment

MeSH terms

Delirium*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Intensive Care Units
Postoperative Complications

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors